Page last updated: 2024-11-05

xylazine and Genetic Predisposition

xylazine has been researched along with Genetic Predisposition in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malm, S1
Strandberg, E1
Danell, B1
Audell, L1
Swenson, L1
Hedhammar, A1

Other Studies

1 other study available for xylazine and Genetic Predisposition

ArticleYear
Impact of sedation method on the diagnosis of hip and elbow dysplasia in Swedish dogs.
    Preventive veterinary medicine, 2007, Mar-17, Volume: 78, Issue:3-4

    Topics: Acepromazine; Age Factors; Animals; Butorphanol; Conscious Sedation; Diagnosis, Differential; Dogs;

2007